NGVT - Ingevity Corp
69.88
-0.780 -1.116%
Share volume: 304,895
Last Updated: 03-04-2026
Chemicals/Chemicals And Allied Products:
0.04%
PREVIOUS CLOSE
CHG
CHG%
$70.66
-0.78
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 10-30-2024 | 02-19-2025 | 05-06-2025 | 08-05-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 2.567 B | 2.276 B | 2.212 B | 2.023 B | 2.056 B | 1.878 B | 1.834 B | 1.651 B | |
| Current Assets | 669.200 M | 685.800 M | 636.800 M | 493.200 M | 530.000 M | 536.000 M | 522.200 M | 454.200 M | |
| Inventories | 325.500 M | 302.000 M | 261.000 M | 226.800 M | 245.400 M | 220.300 M | 193.700 M | 186.000 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 88.500 M | 107.400 M | 135.500 M | 68.000 M | 71.500 M | 76.900 M | 83.400 M | 78.100 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 726.500 M | 722.200 M | 671.300 M | 658.900 M | 655.800 M | 654.600 M | 629.700 M | 608.100 M | |
| Other Assets | 1.171 B | 868.200 M | 903.500 M | 870.500 M | 870.300 M | 687.100 M | 681.900 M | 588.800 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.567 B | 2.276 B | 2.212 B | 2.023 B | 2.056 B | 1.878 B | 1.834 B | 1.651 B | |
| Total liabilities | 1.999 B | 1.991 B | 1.997 B | 1.827 B | 1.822 B | 1.757 B | 1.696 B | 1.621 B | |
| Total current liabilities | 351.700 M | 357.800 M | 360.800 M | 264.100 M | 264.600 M | 393.100 M | 411.600 M | 341.300 M | |
| Accounts Payable | 153.100 M | 142.400 M | 96.500 M | 94.500 M | 108.300 M | 101.500 M | 100.900 M | 92.000 M | |
| Other liabilities | 173.900 M | 171.000 M | 173.000 M | 167.400 M | 165.300 M | 71.200 M | 62.600 M | 62.900 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.409 B | 1.401 B | 1.398 B | 1.340 B | 1.333 B | 1.236 B | 1.159 B | 1.161 B | |
| Other liabilities | 173.900 M | 171.000 M | 173.000 M | 167.400 M | 165.300 M | 71.200 M | 62.600 M | 62.900 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 568.200 M | 284.800 M | 214.500 M | 195.200 M | 234.600 M | 120.700 M | 138.100 M | 29.700 M | |
| Common stock | 169.600 M | 172.000 M | 175.100 M | 177.200 M | 181.300 M | 185.700 M | 191.600 M | 196.100 M | |
| Retained earnings | 946.300 M | 662.600 M | 555.400 M | 572.000 M | 592.500 M | 446.000 M | 489.500 M | 404.900 M |